Recently, interleukin 33 (IL-33), a novel member of the IL-1 family and an alarmin cytokine that acts in response to various kinds of tissue damage1, has emerged as a critical modulator in several autoimmune and inflammatory disorders, including IBD. The gene discussed is IL33; the disease is inflammatory bowel disease.